C80702: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
The primary objective of this study is to compare disease-free survival of subjects with stage III colon cancer randomized to standard chemotherapy only (FOLFOX) or standard chemotherapy (FOLFOX) with 3 years of celecoxib (the study drug) daily.
* Colon Cancer
* Must have had tumor surgically removed
* No evidence of metastatic disease
* Cant be using NSAIDs regularly, or aspirin more than 100mg a day.
18 - 100
Healthy Volunteers Needed
Duration of Participation
Up to 6 years.
Clinical Trials Information Line: Phone 503-494-1080 or email@example.com